Author: Web Desk

Phase 1 trial initiated to assess safety/tolerability and absolute bioavailability of TH104 with topline data expected in 2Q24

Planning well underway for Phase 2 of TH104 in primary biliary cholangitis (PBC) patients suffering from moderate-to-severe chronic pruritus

Company outlines near-clinical pipeline of novel antibody technology for multiple immuno-oncology targets and plans an R&D day in 2024

Company fully funded into 2025 with full readouts of Phase 1 and Phase 2 results for moderate-to-severe chronic pruritus in PBC expected in 4Q24/1Q25

BRIDGEWATER, NJ / ACCESSWIRE / January 29, 2024 / Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation & immunology announces initiation of a Phase 1 trial with TH104, utilizing a proprietary oral thin film. TH104 is a proprietary transmucosal buccal film embedded with the active compound nalmefene onto a thin film which easily adheres inside of the mouth on the cheek and biodegrades within minutes. This provides key features making TH104 an ideal product candidate for multiple liver-related and other pruritogenic inflammatory conditions. The molecule has a dual mechanism of action affecting both the µ-opioid and kappa opioid receptors with emerging data showing inhibition of interleukin-17, a pro-inflammatory cytokine. These well-known opioid receptors when stimulated and/or inhibited by the body’s endogenous ligands have been shown to be involved in the body’s itch circuitry for certain conditions, including cholestatic or dysregulated bile acid-related liver conditions.

TH104/Tharimmune Clinical-Stage Program Update

The Phase 1 clinical trial currently recruiting is a pharmacokinetic bridging study in the U.S. designed as a single-dose, single-center, open-label, randomized 2-way crossover study of TH104 and an intravenous dose of nalmefene administered under fasting conditions, with a 7-day washout period between doses. Sixteen normal healthy volunteers are anticipated to participate and complete the study. The primary objective is to evaluate the absolute bioavailability of TH104 as well as assess safety and tolerability. Topline data is expected in 2Q24 with a full data readout shortly thereafter.

The Company plans to engage both U.S. and European Regulatory Authorities to gain agreement on launching a 28-day Phase 2 trial in 2024 which is currently anticipated as a multiple ascending dose study to assess the safety and tolerability of TH104 while also evaluating the change from baseline for moderate-to-severe chronic pruritus or "debilitating itching" using a validated endpoint, in PBC patients. A topline data readout is anticipated in late ‘24/early ’25, post regulatory discussions, anticipated in 2024. The Company believes the Phase 2 program may establish TH104’s response for clinical efficacy studies in moderate-to-severe pruritus using this potential endpoint for future registrational trials.

Pruritus is a common clinical feature seen in liver diseases but particularly frequent in cholestatic liver disease. A previous open-label study with TH104 in chronic liver disease patients administered a single low-dose of TH104 and assessed itch intensity over a 24-hour period, with topline data showing a decline by 33.3%. Safety and tolerability correlated with previous studies consistent in the literature with nalmefene, the active ingredient in TH104.

TH-3215 and TH-1940/ Tharimmune Non Clinical-Stage Program Update

Tharimmune is advancing TH-3215 designed as a bispecific antibody (BsAb) targeting the extracellular domains of HER2 and HER3. These validated targets have been extensively studied and belong to the ERBB receptor tyrosine kinase family and are exploited by cancer cells to promote tumorigenesis and metastasis. HER2, an extensively studied target, has multiple approved therapeutics for solid tumors. Evidence suggests that HER3 plays a central role through interacting with neighboring receptors. While TH-3215 binds to both overlapping and different epitopes on HER2 in contrast to approved therapies, with ligand-blocking and potential complementary fit to HER3, affecting novel conformational epitopes thought to be important in intracellular downstream signaling in tumor cells.

Furthermore, the Company also is advancing novel Picobodies, which are antibodies in bovine animals or cows, and derived from ultra-long complementary determining region 3 (CDR3) domains which potentially enable access to epitopes that had previously been hidden or highly inaccessible in traditional antibody development. With a much smaller size compared to traditional antibodies, combined with structural diversity, Picobodies can bind to conformational, linear or discontinuous epitopes in "undruggable" areas of validated targets. Picobodies are derived from bovines, which unlike other species, express ultralong CDR-H3 regions forming an independently folding mini-domain, that protrudes far out from the surface of the antibody and is diverse in both its sequence and disulfide patterns. These atypical antigen binding sites of bovines potentially provide the ability to interact with different antigenic determinants capable of eliciting an immune response, particularly recessed or concave surfaces, compared to traditional antibodies. This conceivable "multi-specific" capacity of Picobodies , which is the basis of developing TH-1940, could more efficiently target multiple cell surface portions compared to known or existing biologics. Tharimmune aims to develop both TH-3215 and TH-1940 using this framework to interchange antigen-recognition sites designed to fit distinct portions of the HER2/HER3 heterodimer complex and other validated cancer targets, such as programmed cell death protein 1 or PD-1 potentially effecting both ligand-dependent and independent signaling pathways into tumor cells.

The Company announced in 4Q23 the closing of an $11 million public offering which it believes is sufficient to extend its cash runway into early 2025 for both clinical readouts of its lead program, TH104. Tharimmune plans to advance both its clinical and non-clinical programs and announce an R&D Day in 2Q24 to update stakeholders and patients.

"We are pleased with the progress we’ve made at Tharimmune including the initiation of our Phase 1 clinical trial with TH104 using our proprietary nalmefene embedded transmucosal delivery system which can easily be applied to the inside of the cheek," said Randy Milby, CEO of Tharimmune. "The data we aim to obtain coupled with our plans to engage regulators in a timely manner will aid in potentially bringing this much needed treatment strategy to people suffering from chronic pruritis in PBC. As we continue to transform into a clinical company, we hope to engage shareholders, patients and all stakeholders on the progress of our pipeline over the coming months."

About TH104

TH104 is embedded with nalmefene onto a proprietary transdermal buccal film which easily adheres to the inside of the mouth. This endows TH104 with key features making it an ideal product candidate for multiple liver-related and other pruritogenic inflammatory conditions. The molecule has a dual mechanism of action affecting both the µ-opioid receptor and the kappa opioid receptor as well as inhibiting IL-17 inflammatory cytokine expression. These opioid receptors when stimulated and/or inhibited by the body’s natural ligands have been known to be involved in the body’s itch circuitry.

About Pruritus and Primary Biliary Cholangitis

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, PBC, is a chronic disease where the bile ducts in the liver eventually become dysfunctional and cause the buildup of bile which causes liver damage. The disease, believed to be an autoimmune condition, affects an estimated 58 out of every 100,000 U.S. women and about 15 out of every 100,000 U.S. men. Pruritus is one of the most common symptoms associated with PBC affecting up to 75% of individuals at some point during their disease course. It has a negative impact on health-related quality of life with limited treatment options. Published survey data of PBC respondents suffering from pruritus described their itch as "bugs crawling under the skin". More than 65% of patients reported that the itch was worse at night, known as nocturnal pruritus, a high unmet need.

About Tharimmune

Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. The Company has acquired an exclusive worldwide license for a clinical-stage asset, TH104 known to suppress chronic, debilitating pruritus or "uncontrollable itching" in PBC, a rare and orphan liver disease with no known cure. The Company’s early-stage immunology pipeline includes novel multi-specific antibodies targeting unique epitopes with novel mechanisms of action against well-known, validated targets in multiple solid tumors, including PD-1, HER2 and HER3. Tharimmune has a license agreement with OmniAb, Inc. to access the company’s antibody discovery technology platform against these and other specified targets. For more information please visit: www.tharimmune.com.

Forward Looking Statements
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, contained in this press release, including statements regarding Tharimmune’s strategy, future operations, future financial position, projected costs, prospects, plans and objectives of management, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "depends," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "target," "should," "will," "would," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company may not actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements, and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements. Factors that may cause such differences, include, but are not limited to, those discussed under Risk Factors set forth in our Annual Report on Form 10-K/A for the year ended December 31, 2022 and other periodic reports filed by the Company from time to time with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company’s views as of the date of this release. Subsequent events and developments may cause the Company’s views to change; however, the Company does not undertake and specifically disclaims any obligation to update or revise any forward-looking statements to reflect new information, future events or circumstances or to reflect the occurrences of unanticipated events, except as may be required by applicable law. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of this release.

Investor Relations Contact

ir@tharimmune.com
www.tharimmune.com

SOURCE: Tharimmune, Inc.

View the original press release on accesswire.com

FORT PIERCE, FL / ACCESSWIRE / January 29, 2024 / Twin Vee PowerCats Co. (NASDAQ:VEEE) ("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, today announced organizational realignment initiatives intended to streamline the Company’s size and complexity while leveraging its resources to design and build new boat models and grow its dealer base. As a result of these initiatives, the Company expects to reduce overhead costs and rightsize its operations based on demand as it heads into the 2025 model year in a few months.

Twin Vee’s cost-saving initiatives have included workforce reductions, operational restructuring to become more streamlined, and cutting unnecessary expenses related to its inventory and manufacturing processes. Additionally, the Company is committed to growth by increasing its market share through innovative new boat models that diversify its product offering and appeal to more consumers. "We are continuing to aggressively drive our business toward growth by introducing innovating new products to the market," remarked Joseph C. Visconti, CEO and President of Twin Vee PowerCats Co. In December, Twin Vee announced the launch of three new boat models: the 2024 400 GFX, 280 GFX Dual Console, and Aquasport 2400 Center Console. Twin Vee anticipates that updates to current boat models and all-new boats will debut up to and during the 2025 model year, which begins this summer.

The Company also plans to develop its product awareness outside the State of Florida by introducing new dealers to the Twin Vee and Aquasport brands. "The Company is always seeking boat dealers in markets where customers share our passion for recreational boating," states Visconti. "We believe our boats can attract first-time boat buyers, freshwater boaters, and other water recreation enthusiasts because Twin Vee and Aquasport offer such a variety of products that cater to multiple needs. And given current economic conditions, there’s a significant opportunity to partner with dealerships in new territories and increase our market share by focusing on our 22-foot and 24-foot models since the vast majority of registered powerboats in the country are under 26-feet in length."

According to Visconti, reducing Twin Vee’s organizational complexity and enabling substantial cost savings while simultaneously growing its dealership network will help Twin Vee to serve new and existing customers better and more responsively. Moreover, he believes that these initiatives will allow the Company to remain agile in addressing potential economic challenges Twin Vee may encounter this year. "Based on the state of the marine industry, we believe now is the right time to resize our Company while reducing our overhead. While this is never easy, it is important for Twin Vee’s future. The potential savings are important as we work hard to increase our revenue and further develop a strong dealership network to support our customers and brand across the country," concluded Visconti.

About Twin Vee PowerCats Co.

Twin Vee is a designer, manufacturer, distributor, and marketer of power sport boats. The Company is located in Fort Pierce, Florida, and has been building and selling boats for nearly 30 years. Learn more at twinvee.com. Twin Vee is one of the most recognizable brand names in the catamaran sport boat category and is known as the "Best Riding Boats on the Water."

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of the words "could," "believe," "anticipate," "intend," "estimate," "expect," "may," "continue," "predict," "potential," "project" and similar expressions that are intended to identify forward-looking statements and include statements regarding organizational realignment initiatives streamlining the Company’s size and complexity while leveraging its resources to design and build new boat models and grow its dealer base, reducing the Company’s overhead costs and rightsizing its operations based on demand, cutting unnecessary expenses related to inventory and manufacturing processes, increasing market share through innovative new boat models that diversify the Company’s product offering and appeal to more consumers, continuing to aggressively drive our business toward growth by introducing innovating new products to the market, debuting updates to current boat models and all-new boats up to and during the 2025 model year, plans to develop product awareness outside the State of Florida by introducing new dealers to the Twin Vee and Aquasport brands, attracting first-time boat buyers, freshwater boaters, and other water recreation enthusiasts, the opportunity to partner with dealerships in new territories and increase market share by focusing on the Company’s 22-foot and 24-foot models, reducing organizational complexity and enabling substantial cost savings while simultaneously growing its dealership network helping the Company serve new and existing customers better and more responsively, remaining agile in addressing potential economic challenges this year, being the right time to resize the Company while reducing its overhead and the potential savings being important as the Company works hard to increase its revenue and further develop a strong dealership network to support its customers and brand across the country. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the Company’s ability to reduce its overhead costs and achieve the potential savings expected through its organizational realignment initiatives to streamline the Company’s size and complexity while leveraging its resources to design and build new boat models and grow its dealer base, the Company’s ability to increase market share through innovative new boat models that diversify its product offering and appeal to more consumers, the Company’s ability to debut updates to current boat models and all-new boats as planned, the Company’s ability to develop product awareness outside the State of Florida by introducing new dealers to the Twin Vee and Aquasport brands, the Company’s ability to attract first-time boat buyers, freshwater boaters, and other water recreation enthusiasts, the Company’s ability to partner with dealerships in new territories and increase market share by focusing on the Company’s 22-foot and 24-foot models, the Company’s ability to reduce organizational complexity and enable substantial cost savings while simultaneously growing its dealership network and serving new and existing customers better and more responsively, the Company’s ability to address potential economic challenges this year, and the risk factors described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, the Company’s Quarterly Reports on Form 10-Q, the Company’s Current Reports on Form 8-K and subsequent filings with the SEC. The information in this release is provided only as of the date of this release, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events, except as required by law.

Contact:

Glenn Sonoda
investor@twinvee.com

SOURCE: Twin Vee PowerCats Co.

View the original press release on accesswire.com

Partnering to equip event personnel and volunteers with turnkey communication solution

VANCOUVER, BC / ACCESSWIRE / January 29, 2024 / Siyata Mobile Inc. (Nasdaq:SYTA, SYTAW) ("Siyata" or the "Company"), a global developer and vendor of Push-to-Talk over Cellular (PoC) handsets and accessories, announces it is providing its SD7 handsets for use at the 2024 Special Olympics. The Company has partnered with ESChat, a provider of broadband Push-to-Talk (PTT) services, to provide secure PTT communications for event personnel and volunteers.

The 2024 Special Olympics State Winter Games will be held on and between February 23-24, 2024 in Syracuse, NY.

Siyata CEO, Marc Seelenfreund, commented, "We are honored to support the Special Olympics again this year and renew our partnership with ESChat. ESChat’s PTT service integrated with our ruggedized handsets creates a comprehensive, turnkey solution that provides secure communications that will help keep athletes, coaches, volunteers and spectators safe by keeping event personnel reliably connected."

The SD7 enables push-to-talk communications for users in a simple easy-to-use rugged Android based Push-To-Talk (PTT) handset with excellent sound quality that operates over a high bandwidth 4G LTE network to provide consistent connectivity. Its IP68 rating, resistance to water and dust, drop protection, and robust battery make it well suited for use in harsh winter conditions. Users of the SD7 can initiate and receive talk-group calls, receive private calls, notify others of emergencies and report locations.

President of ESChat, Josh Lober, said, "We’ve seen strong adoption across our markets for ESChat service on the Siyata SD7. EMS communication is a primary focus of our company, so working with the Special Olympics is a natural fit. The 2024 Winter Games in Syracuse will be the sixth Special Olympics event we have served, and we’re proud to be recognized as an official sponsor of the Special Olympics of New York (SONY). The combination of the Siyata SD7 and ESChat will once again provide SONY personnel a seamless and secure communications solution that is ready to operate, easy to use and most importantly, supports a safe and successful event."

About ESChat:

ESChat (eschat.com) is the leading solution for broadband Push-to-Talk (PTT) services. ESChat is a FirstNet Certified solution and is also approved by the Defense Information Systems Agency (DISA) for U.S. military operational use. ESChat operates on and across all wireless carriers, providing intercarrier interoperability. ESChat supports Quality of Service (QoS), Radio Access Network (RAN) Priority, and Preemption enhancements available to FirstNet subscribers, as well as QoS and RAN priority enhancements on the Verizon Wireless and AT&T commercial networks. In North America, ESChat is the primary PTT offering by T-Mobile and TELUS.

About Siyata Mobile

Siyata Mobile Inc. is a B2B global developer and vendor of next-generation Push-To-Talk over Cellular handsets and accessories. Its portfolio of rugged PTT handsets and accessories enables first responders and enterprise workers to instantly communicate over a nationwide cellular network of choice, to increase situational awareness and save lives. Police, fire, and ambulance organizations as well as schools, utilities, security companies, hospitals, waste management companies, resorts and many other organizations use Siyata PTT handsets and accessories today.

In support of our Push-to-Talk handsets and accessories, Siyata also offers enterprise-grade In-Vehicle solutions and Cellular Booster systems enabling our customers to communicate effectively when they are in their vehicles, and even in areas where the cellular signal is weak.

Siyata sells its portfolio through leading North American cellular carriers, and through international cellular carriers and distributors.

Siyata’s common shares trade on the Nasdaq under the symbol "SYTA" and its previously issued warrants trade on the Nasdaq under the symbol "SYTAW."

Visit www.siyata.net and unidencellular.com to learn more.

Investor Relations (Canada):

Kin Communications
1-866-684-6730
SYTA@kincommunications.com

Investor Relations (United States):

Brett Maas
Hayden IR
SYTA@Haydenir.com
646-536-7331

Siyata Mobile Corporate:

Glenn Kennedy, VP of International Sales
Siyata Mobile Inc.
glenn@siyata.net

ESChat Corporate:

media@eschat.com

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on Siyata’s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Siyata could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in Siyata’s filings with the Securities and Exchange Commission ("SEC"), and in any subsequent filings with the SEC. Except as otherwise required by law, Siyata undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites and social media have been provided as a convenience, and the information contained on such websites or social media is not incorporated by reference into this press release.

SOURCE: Siyata Mobile Inc.

View the original press release on accesswire.com

At the Adopting Bitcoin Cape Town event, Ehsani shed light on the significance of Bitcoin and how the Bitcoin community as well as the wider industry can make a real contribution to the advancement of civilization

JOHANNESBURG, SOUTH AFRICA / ACCESSWIRE / January 29, 2024 / After an extremely successful year that saw VALR take the lead the largest cryptocurrency exchange by trading volume in Africa, its CEO Farzam Ehsani delivered the opening keynote to attendees at the recent Adopting Bitcoin Cape Town event that took place at the Cape Town International Convention Center this month. In a lively keynote address, Ehsani discussed the numerous ways in which VALR is supporting the growing adoption of Bitcoin by Africans, and how the industry as a whole is making a significant contribution to humanity’s economic and technological progress.

Ehsani’s speech, titled "Integration Versus Disintegration: Bitcoin Adoption and Human Progress", gave insight into some of the key drivers of VALR’s success in advancing the adoption of Bitcoin in Africa, and offered important reflections on principles such as unity, service and truth.

The talk centered on the broader theme of the forces of disintegration and integration unfolding at every level of society, while also exploring the significance of the emergence of Bitcoin as a unifying force and important technology to align global finance with the needs of this age. In particular, visitors were able to learn about the efforts made by VALR to help establish Bitcoin as a viable method of payment, such as through its recently announced partnership with Visa, which is set to allow VALR customers to use that company’s network to send and receive payments from any location in the world. As part of that collaboration, VALR is planning to launch a number of innovative payment and card products that will enable users to leverage Visa’s network in their transactions.

Directing his comments on the topic of Bitcoin adoption directly at the Bitcoin community, Ehsani said:

"We need to look into the mirror sometimes as the Bitcoin community. There are times when we sow division in our discourse. When we talk about us versus them, when we talk about the Bitcoiners versus the bankers, about Bitcoiners versus the no coiners, sometimes, while we’re having fun and it’s enjoyable, we’re actually retarding the progress of our own cause."

"If we truly believe that Bitcoin is here to progress humanity, to move us forward, then it’s not just for Bitcoiners, it’s for the world. We cannot disparage those that don’t quite understand it yet, we have to welcome them because Bitcoin really is for everyone" continued Ehsani.

In addition, at the event, visitors were able to learn about VALR’s partnership with CryptoConvert, enabling users to spend their Bitcoin on groceries and various other products at Pick n Pay stores throughout South Africa.

Adopting Bitcoin Cape Town is the latest in a series of global crypto conferences that explore the unique overlap between Bitcoin and the emergence of other so-called parallel institutions that service and empower humanity amidst widespread socio-economic disintegration. The event welcomed dozens of top local and international crypto entrepreneurs and influencers to discuss the latest advances in Bitcoin’s development and the impact it is having on the world in the context of real-world economies and institutions.

VALR’s participation at Bitcoin Adoption Cape Town is significant, as it has made great strides in cementing its status as Africa’s leading digital asset exchange. Last year saw the launch of a perpetual futures trading product that offers the world’s first Bitcoin and USDT perpetuals traded against the South African Rand. Also last year, VALR added spot margin trading features, received regulatory approval for its services in Europe, and kicked off the process of obtaining licenses in Dubai and Mauritius. So far, it has already secured initial approval from Dubai’s Virtual Assets Regulatory Authority (VARA).

About VALR

VALR is a global crypto exchange serving over 900 corporate and institutional clients, and more than half a million users around the world. Headquartered in Johannesburg, South Africa, with approval to offer services in Europe, VALR has processed over $15 billion in trading volume and secured $55 million in equity funding from reputable investors like Coinbase Ventures, Pantera Capital, and Avon Ventures, affiliated with the parent company of Fidelity Investments.

CONTACT:
VALR
info@valr.com

SOURCE: VALR

View the original press release on accesswire.com

Foremost Farms is the most recent company to join a national movement to turn food waste into renewable energy

BOSTON, MA / ACCESSWIRE / January 29, 2024 / Vanguard Renewables®, a national leader in organics-to-renewable energy production, is excited to announce the addition of Foremost Farms USA®, one of the largest dairy cooperatives in the United States, to the Farm Powered Strategic Alliance (FPSA). This strategic partnership marks a significant milestone in the pursuit of sustainable organic waste reduction and renewable energy generation within the dairy industry.

Foremost Farms, owned by hundreds of dedicated Midwest dairy farm members across seven states, has long been recognized for its commitment to producing high-quality milk used in the creation of award-winning cheese, butter and dairy ingredients. By joining the FPSA, Foremost Farms aims to further strengthen its dedication to sustainable practices and support generational dairy farmers across America.

"We are delighted to welcome Foremost Farms to the FPSA," said Neil H. Smith, Chief Executive Officer of Vanguard Renewables. "Their members’ commitment to sustainable farming practices is helping to create a more sustainable future for the dairy industry, and their desire to work with and learn from like-minded organizations to explore solutions for food waste aligns with our mission."

The FPSA, a collaborative initiative focused on driving systemic change, is dedicated to promoting sustainable organic waste reduction and regenerative agriculture solutions. With the addition of Foremost Farms, the Alliance gains a valuable partner with extensive experience in sustainable agriculture and is dedicated to supporting America’s dairy farmers.

"Foremost Farms is dedicated to building strong partnerships with organizations that focus on sustainability in the dairy industry," said Greg Schlafer, President and CEO of Foremost Farms. "We’re pleased to join the FPSA as another step in continuing our trajectory as environmental stewards that take care of our world and create value for dairy farm families."

Vanguard Renewables partners with food and beverage manufacturers to recycle their inedible food waste via Farm Powered® anaerobic digestion, which converts organic waste into renewable natural gas (RNG). This RNG is then used to generate electricity, heat, and transportation fuel, reducing reliance on fossil fuels and mitigating greenhouse gas emissions. By diverting food waste from landfills and transforming it into clean energy, Vanguard Renewables is making a significant impact on the environment while also creating economic opportunities for farmers and local communities.

"This partnership allows Foremost Farms to amplify our commitment to sustainability and support our members in their efforts," said Rachel Turgasen, Senior Director of Member Relations and Corporate Sustainability at Foremost Farms. "Together we will drive positive change in the dairy industry and contribute to a more sustainable future."

The Alliance continues to grow, with Foremost Farms joining other industry leaders such as Danone, AstraZeneca, Unilever, Starbucks, and 15 other national partners. This collaboration of like-minded companies is working to make a lasting impact across industries and setting a new standard for sustainability and environmental stewardship.

For more information about Vanguard Renewables and the Farm Powered Strategic Alliance, please visit https://bit.ly/FPSA23.

Visit Vanguard’s Media Room:

https://www.vanguardrenewables.com/media-kit

About Vanguard Renewables:

Vanguard Renewables, based in Weston, Massachusetts, is a national leader in developing food and dairy waste-to-renewable energy projects. The Company owns and operates on-farm anaerobic digester facilities in the northeast and currently operates manure-only digesters in the south and west for Dominion Energy. Vanguard Renewables plans to expand nationwide to more than 150 anaerobic digestion facilities by 2026. Vanguard Renewables is committed to advancing decarbonization by reducing greenhouse gas emissions from farms and food waste, generating renewable energy, and supporting regenerative agriculture on partner farms via Farm Powered® anaerobic digestion.  Vanguard Renewables is a portfolio company of BlackRock Real Assets. To learn more visit vanguardrenewables.com.

About Foremost Farms:

Foremost Farms USA® is a dairy cooperative representing hundreds of Midwest dairy farmer members located across seven Midwest states, including Illinois, Indiana, Iowa, Michigan, Minnesota, Ohio and Wisconsin – America’s Dairyland. It is one of the largest, leading dairy cooperatives in the United States and a major food manufacturing business. Every year, Foremost Farms produces millions of pounds of cheese, butter, whey and milk protein ingredients from the high-quality milk produced by its members. Its customers represent respected top brands and category leaders at national and regional levels in retail and foodservice channels, that are served with innovative solutions, technical services and customized products. For more information, see foremostfarms.com.

View additional multimedia and more ESG storytelling from Vanguard Renewables on 3blmedia.com.

Contact Info:
Spokesperson: Vanguard Renewables
Website: https://www.3blmedia.com/profiles/vanguard-renewables
Email: info@3blmedia.com

SOURCE: Vanguard Renewables

View the original press release on accesswire.com